BIOMAT Database Logo BIOMAT Database Logo

Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab. 2006

C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013167 Spondylitis, Ankylosing A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions. Ankylosing Spondylitis,Bechterew Disease,Marie-Struempell Disease,Rheumatoid Spondylitis,Spondylarthritis Ankylopoietica,Ankylosing Spondylarthritis,Ankylosing Spondyloarthritis,Bechterew's Disease,Spondylitis Ankylopoietica,Spondyloarthritis Ankylopoietica,Ankylosing Spondylarthritides,Ankylosing Spondyloarthritides,Bechterews Disease,Marie Struempell Disease,Spondylarthritides, Ankylosing,Spondylarthritis, Ankylosing,Spondylitis, Rheumatoid,Spondyloarthritides, Ankylosing,Spondyloarthritis, Ankylosing
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
January 2008, Clinical and experimental rheumatology,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Concomitant systemic lupus erythematosus and ankylosing spondylitis.
May 1990, Annals of the rheumatic diseases,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Secukinumab-induced systemic lupus erythematosus occurring in a patient with ankylosing spondylitis.
May 2022, Rheumatology (Oxford, England),
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
[A pedigree with systemic lupus erythematosus and ankylosing spondylitis].
June 2013, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Infliximab-induced systemic lupus erythematosus.
October 2002, Annals of internal medicine,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Coexistence of ankylosing spondylitis and systemic lupus erythematosus.
May 2010, Journal of the Chinese Medical Association : JCMA,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.
February 2009, Rheumatology international,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Ankylosing spondylitis in female systemic lupus erythematosus: a rare combination.
June 2011, Lupus,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
Cervical tuberculous spondylitis associated with systemic lupus erythematosus.
October 2001, Spinal cord,
C Pérez-García, and J Maymo, and M P Lisbona Pérez, and M Almirall Bernabé, and J Carbonell Abelló
[Coexistence of ankylosing spondylitis and systemic lupus erythematosus (case report)].
January 1978, Reumatologia,
Copied contents to your clipboard!